Explanation
Relapsingremitinamutiple sderosisRRMS
Interferonbetaisucensedforuse inpatientswithRRMSwhoareabletowakunaided
RRMSisdefinedas havinaateasttwo attacksofneuroloqicaudvsfunction(relapses)overtheprevious
2years.
CunicaLtiaushaveshownthatinterferonisassociated wtamodestreductonnreuapsefrequency
(around 30)butconvincingevidenceregardingtheeffect onuong-term proqnosis anddisease
proqression(egtmetakentoevolveintosecondary progressiveMS) remains eusive.
Interferonbetaisgivenaseither subcutaneousinjectionthreetimesper week or intramuscular injection
onceweekly. Adverseeffects includeocauinfuammatorvreactions atiniection sites.ftu-uikesvmptoms
anddepression.
Somepatientsdevelopanti-druqantibodies against interferonthatumtitsefficacyv Inthis case,a
switchtoanaternativedrug(egglatiramer acetate) is usually advocated.
@1MI
